Biogx Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Biogx

Access the complete profile.

Biogx Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325413 In-Vitro Diagnostic Substance Manufacturing 42345 Medical, Dental & Hospital Equipment & Supplies Merchant Wholesalers
Address	2450 Valleydale Rd Hoover, AL 35244

Note: Revenues for privately held companies are statistical evaluations.


Biogx's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Biogx's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Biogx is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Biogx Annual Revenue and Growth Rate

Biogx	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Biogx's revenues are gauged from an analysis of company filings.

Biogx's Income Statement (based on Industry Averages)

Biogx P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Biogx is developing and marketing. Biogx doesn't have any recent trademark applications, indicating Biogx is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PIXL Scientific instrument for performing real-time polymerase chain reaction (PCR); scientific instrument for performing real-time PCR for point of care purposes; scientific instrument for performing quantitative polymerase chain reaction (qPCR)	05/21/2021
XFREE Medical diagnostic tests for infectious and genetic diseases; medical diagnostic tests including reagents to test for infectious and genetic diseases; medical diagnostic tests employing polymerase chain reaction (PCR) to test for infectious and genetic diseases; reagents, namely, reagents for medical diagnostic testing use; molecular reagents, namely, lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, custom lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, lyophilized reagents for chemical testing purposes, namely, clinical medical reagents and chemical reagents for medicinal pharmaceutical use; molecular reagents, namely, molecular reagents for medical diagnostic use in connection with genetic materials; molecular reagents, namely, molecular reagents for medical diagnostic use in real-time PCR and nucleic sequencing platforms	09/24/2020
SAMPLE READY JUST ADD WATER Reagents, namely, reagents for medical diagnostic testing use; molecular reagents, namely, lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, custom lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, lyophilized reagents for chemical testing purposes, namely, clinical medical reagents and chemical reagents for medicinal pharmaceutical use; molecular reagents, namely, molecular reagents for medical diagnostic use in connection with genetic materials; molecular reagents, namely, molecular reagents for medical diagnostic use in real-time PCR and nucleic sequencing platforms	12/19/2018

See all trademarks and details in the Full Report.

Market Share of Biogx's Largest Competitors

A competitive analysis shows these companies are in the same general field as Biogx, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Biogx. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOHORIZONS IMPLANT SYSTEMS	Birmingham, AL	100
PACK HEALTH	Birmingham, AL	28
SOUTHERN RESEARCH INSTITUTE	Birmingham, AL	16
BIOGX	Hoover, AL	10
PROTEUS MOLECULAR & CLINICAL LAB	Homewood, AL	3
QUINLAN PARTNERS	Birmingham, AL	3

Future Competition: Biogx's Fastest Growing Competitors

These companies are in the same general field as Biogx and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)